Syncona

SYNC: 218.00 -2.50 (-1.13%) delayed: 6 Dec 2019, 17:30

Trade now

Syncona Fundamentals

Share Price Information

Name Syncona
Epic SYNC
Sector Equity Investment Instruments
ISIN GG00B8P59C08
Activites Syncona Limited (formerly BACIT Limited) is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Its vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
Index FTSE 250

Key numbers

Latest Share price (p) 218.00 Net gearing (%) 1.61
Market capitalisation (£m) 1,463.38 Gross gearing (%) 1.62
Shares in issue (m) 663.67 Debt ratio 0.74
P/E ratio 214.08 Debt-to-equity ratio 0.45
Total dividends per share (p) 2.30 Assets / equity ratio 1.02
Dividend yield (%) 1.04 Price to book value 1.01
Dividend cover 0.45 ROCE (%) 15.01
Earning per share (p) 1.03 EPS growth (%) 32.05
52-week high / low (p) 303.50 / 212.00 DPS growth (%) 0.00

Results at a glance

Date Type Turnover (£m) Profit (£m) Basic EPS Currency
31 Mar 2019 Full Year 0 0 1.03 GBP
31 Mar 2018 Full Year 0 0 0.78 GBP
31 Mar 2017 Full Year 0 0 1.28 GBP

Dividend history

Period Ex-date Pay-date Net dividend Currency Total for year
H2 Dividend 20 Jun 2019 29 Jul 2019 2.30 GBX 2.30
H2 Dividend 21 Jun 2018 30 Jul 2018 2.30 GBX 2.30
H2 Dividend 20 Jul 2017 23 Aug 2017 2.30 GBX 2.30
H2 Dividend 14 Jul 2016 19 Aug 2016 2.20 GBX 2.20
H2 Dividend 16 Jul 2015 19 Aug 2015 2.10 GBX 2.10

Contact details

Company name Syncona Limited
Address 2nd Floor, 10 Aldermanbury, London EC2V 7RF.
Telephone +44 (0)20 3603 0453
Website http://www.synconaltd.com/

Advisors

Company's broker JPMorgan Cazenove
Company's joint broker n/a
NOMAD JPMorgan Cazenove
Registrar Link Asset Services
Auditors Deloitte & Touche LLP
Solicitors Freshfields Bruckhaus Deringer LLP

Directors

Appointed Director Position
26 Oct 2012 Jeremy John Tigue Non-Executive Chairman
26 Oct 2012 Thomas Alexander Gavin Henderson Non-Executive Director
01 Nov 2017 Robert Hutchinson Non-Executive Director
20 Dec 2016 Nigel John Keen Non-Executive Director
26 Oct 2012 Nicholas David Moss Non-Executive Director
01 Apr 2018 Gian Piero Reverberi Non-Executive Director
20 Dec 2016 Dr Ellen Ruth Strahlman Non-Executive Director

Company financials

Assets (£m) 2019 2018 2017
Reporting date 31 Mar 2019 31 Mar 2018 31 Mar 2017
Tangible assets 0 0 0
Intangible asssets and goodwill 0 0 0
Investments and other non-current assets 1,470 1,065 896
Total non-current assets 1,470 1,065 896
Inventory / work in progress 0 0 0
Trade and other receivables 9 5 5
Cash and equivalents 0 1 0
Other current assets and asset held for resale 0 0 0
Total of all assets 1,479 1,071 901
Liabilities (£m) 2019 2018 2017
Short term liabilities 13 11 6
Long term liabilities 11 4 0
Other liabilites / pension etc 0 0 0
Total of all liabilities 24 15 6
Net assets (£m) 2019 2018 2017
Net assets 1,455 1,056 895
Equity (£m) 2019 2018 2017
Share capital 766 763 760
Minority interests 0 0 0
Retained earnings 0 0 0
Share premium account 0 0 0
Other equity 689 293 135
Total equity 1,455 1,056 895
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 0 8 7
Cashflow before financing 11 13 -158
Increase / decrease in Cash -1 1 0
Income (£m) 2019 2018 2017
Turnover 0 0 0
Cost of sales 0 0 0
Gross profit 0 0 0
Operating profit 0 0 0
Pre-tax profit 220 160 136
Profit / loss for the year 0 0 0